Zepp Health Corporation (ZEPP) P/E Ratio History
Historical price-to-earnings valuation from 2020 to 2022
Loading P/E history...
ZEPP Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Zepp Health Corporation (ZEPP) trades at a price-to-earnings ratio of -3.0x, with a stock price of $14.95 and trailing twelve-month earnings per share of $-30.29.
The current P/E is 235% below its 5-year average of 2.2x. Over the past five years, ZEPP's P/E has ranged from a low of 0.4x to a high of 3.8x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Technology sector median P/E of 27.7x, ZEPP trades at a 111% discount to its sector peers. The sector includes 359 companies with P/E ratios ranging from 0.0x to 184.2x.
Relative to the broader market, ZEPP trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ZEPP DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ZEPP P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $47B | 28.2 | 2.63 | +18% | |
| $1B | 12.2Lowest | 0.51Best | -26% | |
| $4.2T | 38.5 | 2.16 | +23% | |
| $33B | 15.8 | - | -2% | |
| $4.8T | 36.8 | 1.23 | +34%Best | |
| $214B | 40.4 | 19.44 | -44% | |
| $10B | 21.1 | - | -17% | |
| $260B | 52.3 | - | +5% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ZEPP Historical P/E Data (2020–2022)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $5.80 | $3.18 | 1.8x | -17% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $5.48 | $13.10 | 0.4x | -81% |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $20.20 | $15.02 | 1.3x | -39% |
| FY2020 Q4 | $47.40 | $12.37 | 3.8x | +74% | |
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $51.40 | $14.27 | 3.6x | +63% |
Average P/E for displayed period: 2.2x
See ZEPP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZEPP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZEPP vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonZEPP — Frequently Asked Questions
Quick answers to the most common questions about buying ZEPP stock.
Is ZEPP stock overvalued or undervalued?
ZEPP trades at -3.0x P/E, below its 5-year average of 2.2x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does ZEPP's valuation compare to peers?
Zepp Health Corporation P/E of -3.0x compares to sector median of 27.7x. The discount suggests lower growth expectations or higher risk.
What is ZEPP's PEG ratio?
ZEPP PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2020-2022.